← Back to Analyst Consensus 
KURA Buy
Kura Oncology, Inc.
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 1, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| Aug 24, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Aug 13, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Jul 28, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Jun 15, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Apr 14, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Mar 24, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 13, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 6, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Jan 13, 2026 | Leerink Partners | maintain | Outperform → Outperform | $20 | 51% |
| Jan 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Nov 24, 2025 | Barclays | maintain | Overweight → Overweight | $28 | 53% |
| Nov 14, 2025 | UBS | maintain | Buy → Buy | $16 | 54% |
| Nov 14, 2025 | Wedbush | maintain | Outperform → Outperform | $38 | 58% |
| Oct 20, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $24 | 53% |
| Oct 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Sep 30, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Sep 4, 2025 | Guggenheim | initiate | — → Neutral | $0 | 52% |
| Aug 11, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $24 | 53% |
| Jun 26, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Jun 20, 2025 | Wedbush | reiterate | Outperform → Outperform | $36 | 58% |
| Jun 4, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $28 | 53% |
| May 19, 2025 | Mizuho | maintain | Outperform → Outperform | $30 | 52% |
| May 2, 2025 | Barclays | maintain | Overweight → Overweight | $11 | 53% |
| Apr 29, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $28 | 53% |
| Apr 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Mar 6, 2025 | UBS | maintain | Buy → Buy | $14 | 54% |
| Feb 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Feb 6, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $28 | 53% |
| Feb 6, 2025 | Wedbush | maintain | Outperform → Outperform | $36 | 58% |
| Feb 6, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Jan 8, 2025 | Scotiabank | maintain | Sector Perform → Sector Perform | $10 | 55% |
| Dec 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Nov 26, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Nov 22, 2024 | B of A Securities | maintain | Buy → Buy | $29 | 53% |
| Nov 21, 2024 | TD Cowen | reiterate | — → Buy | $0 | 54% |
| Nov 21, 2024 | Jefferies | maintain | Buy → Buy | $28 | 52% |
| Nov 21, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Nov 21, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $37 | 44% |
| Nov 19, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $32 | 53% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
| Nov 6, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
| Oct 24, 2024 | UBS | initiate | — → Buy | $27 | 54% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
| Oct 14, 2024 | Stifel | downgrade | Buy → Hold | $19 | 53% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 12, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $32 | 53% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
Price Target Trend
Jul 19, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days